Protocol summary

Study aim
Comparison of the effect of ketamine with propofol on the bispectral index number in patients who are candidates for elective colorectal surgery in 2024 in Imam Khomeini hospital complex
Design
A controlled, parallel-group, double-blind, randomized, phase 3 clinical trial on 128 patients
Settings and conduct
This study is a double-blind clinical trial (participants and data analysis team). Patients who are candidates for elective colorectal surgery with a minimum duration of two hours referring to the operating room of Mahdi Clinic are randomly divided into two matched intervention and control groups. Monitoring of patients during anesthesia includes routine monitoring and two-dimensional index to check the depth of anesthesia. The changes of the two-dimensional index number are compared between the two groups. After anesthesia, the patients are asked about recalling the events during anesthesia and pain after the operation, and comparison is made between the two groups. Also, postoperative anesthesia complications are also compared between the two groups.
Participants/Inclusion and exclusion criteria
Candidates for elective colorectal surgeries with a minimum duration of two hours referring to the operating room of Mahdi Clinic with ASA 1&2 without exclusion criteria (two spectrums of body mass index, hypertension, psychiatric disorders)
Intervention groups
In the intervention group, ketamine is used as an intravenous anesthetic to induce and maintain anesthesia. In the control group, propofol is used as an intravenous anesthetic to induce and maintain anesthesia. Both groups use atracurium during intubation and then as an infusion during the operation for motor relaxation. Fentanyl infusion and morphine sulfate bolus are used in half an hour before the end of the operation in similar amounts.
Main outcome variables
Bispectral index, recall and complications after anesthesia

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20170709034978N4
Registration date: 2024-08-25, 1403/06/04
Registration timing: prospective

Last update: 2024-08-25, 1403/06/04
Update count: 0
Registration date
2024-08-25, 1403/06/04
Registrant information
Name
Mojgan Rahimi
Name of organization / entity
Tehran University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 84426391
Email address
mrahimi@tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2024-09-21, 1403/06/31
Expected recruitment end date
2025-01-19, 1403/10/30
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of the effect of ketamine with propofol on the bispectral index number in patients who are candidates for elective colorectal surgery in 2024 in Imam Khomeini hospital complex
Public title
Changes of Bispectral Index in Ketamine Anesthesia
Purpose
Basic scienece
Inclusion/Exclusion criteria
Inclusion criteria:
Patients calssified as ASA 1&2 who are candidates for elective colorectal surgery with a minimum duration of 2 hours admitted to Mahdi clinic operating room
Exclusion criteria:
Two entities of BMI (<18 or >30) Hypertension Pscychiatric disorders Denial for consent to participate in the study
Age
No age limit
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Data analyser
Sample size
Target sample size: 128
Randomization (investigator's opinion)
Randomized
Randomization description
In this study, we will use the restricted randomization method of the block randomization type. Blocking is usually used in order to balance the number of samples assigned to each of the studied groups. This feature helps the researchers so that the number of samples assigned to each of the studied groups is equal in cases where intermediate analyzes are needed during the sampling process. The size of all the blocks is equal and we will have 8 blocks of 8 in this two-group experiment (including 4 participants in the intervention group and 4 participants in the control group). Then, in order to randomly select the produced blocks, random number generation software such as R language is used and 8 numbers will be randomly generated from 1 to 8 to select the blocks. For concealment, we use allocation concealment, which refers to the method used to perform a random sequence on study participants, so that the allocated group is not known before the individual is allocated. By using opaque letter envelopes sealed with a random sequence (Sequentially numbered, sealed, opaque envelopes), in this method, each of the random sequences created is recorded on a card, and the cards are placed inside the letter envelopes in order They are placed. In order to maintain a random sequence, the outer surface of the envelopes is numbered in the same order. Finally, the lid of the letter envelopes is glued and placed in a box. At the time of registration of the participants, based on the order in which the eligible participants entered the study, one of the envelopes will be opened and the assigned group of that participant will be revealed.
Blinding (investigator's opinion)
Double blinded
Blinding description
People participating in the study after informed consent and not having exclusion criteria are randomly placed in one of the control or intervention groups, while they do not know about their group. All procedures and drugs prescribed before induction of anesthesia in the two groups have the same sequence and there is no mention of the type of drug prescribed. After regaining consciousness and transferring to the recovery room, the participants are not given an explanation about the details of the anesthesia method adopted. The data analysis team receives the data in such a way that the name of the group is not known. These people are not specialized in the field of anesthesia, so they cannot find out the group from the difference in the data. They analyze the data in the same way and deliver the results to the researchers.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics committee of Tehran University of Medical Sciences
Street address
Headquarters of Tehran University of Medical Sciences, Qods St., Keshavarz Blvd.
City
Tehran
Province
Tehran
Postal code
1461884513
Approval date
2024-08-05, 1403/05/15
Ethics committee reference number
IR.TUMS.IKHC.REC.1403.213

Health conditions studied

1

Description of health condition studied
Elective colorectal surgeries
ICD-10 code
ICD-10 code description

Primary outcomes

1

Description
Changes in Bispectral index
Timepoint
Before premedication, before induction, before intubation, after intubation, before 1st surgical stimulation, 5 minutes after 1st surgical stimulation, mean during operation, before reversal of neuromuscular block, before extubation, after extubation
Method of measurement
Depth of anesthesia monitoring device by the method of bispectral index

Secondary outcomes

1

Description
recall of anesthesia
Timepoint
After emergence from anesthesia in recovery ward
Method of measurement
Modified Brice questionnare

Intervention groups

1

Description
Intervention group: In the intervention group, ketamine is used as an intravenous anesthetic to induce (2-2.5 mg/kg) and maintain (50 mcg/kg/min) anesthesia. For movement relaxation, atracurium bolus dose of 0.5 mg/kg is used during intubation and as an infusion with a dose of 10 mcg/kg/min during the operation and it is stopped in about an hour before the end of the operation. Also, for intraoperative analgesia, fentanyl infusion (100 mcg/hr) and bolus dose of morphine sulfate (0.1 mg/kg) are used in the last half hour of surgery in similar amounts. Monitoring of patients during anesthesia includes the standard monitoring of the American Society of Anesthesiologists (non-invasive blood pressure, heart rate, pulse oximetry, ECG and capnography) and bispectral index to check the depth of anesthesia (before the start of the anesthesia process). Changes in vital signs and signs of easing the depth of anesthesia (tears and sweating) are recorded during anesthesia.
Category
Treatment - Drugs

2

Description
Control group: In the control group, propofol is used as an intravenous anesthetic for induction (2 mg/kg) and maintenance of anesthesia (100-150 mcg/kg/min). For movement relaxation, atracurium bolus dose of 0.5 mg/kg is used during intubation and as an infusion with a dose of 10 mcg/kg/min during the operation and it is stopped in about an hour before the end of the operation. Also, for intraoperative analgesia, fentanyl infusion (100 mcg/hr) and bolus dose of morphine sulfate (0.1 mg/kg) are used in the last half hour of surgery in similar amounts. Monitoring of patients during anesthesia includes the standard monitoring of the American Society of Anesthesiologists (non-invasive blood pressure, heart rate, pulse oximetry, ECG and capnography) and bispectral index to check the depth of anesthesia (before the start of the anesthesia process). Changes in vital signs and signs of easing the depth of anesthesia (tears and sweating) are recorded during anesthesia.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Imam Khomeini hospital complex
Full name of responsible person
Seyyed Hasan Inanlu
Street address
Dr. Qarib St., Keshavarz Blvd.
City
Tehran
Province
Tehran
Postal code
1419733141
Phone
+98 21 6119 0000
Email
Imamhospital@tums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Ali Akbari Sari
Street address
Research and Technology Vice-Chancellor, 6th floor, Central Organization of Tehran University of Medical Sciences, Qods St., Keshavarz Blvd.
City
Tehran
Province
Tehran
Postal code
1461884513
Phone
+98 21 8163 3698
Email
vcr@sina.tums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Tehran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Alireza Rezaee
Position
Clinical resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
No. 8, Samadi Alley, Khojastehpoor St., Sattari HW.
City
Tehran
Province
Tehran
Postal code
1473713383
Phone
+98 21 6119 0000
Email
a_rezaee97@yahoo.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Mojgan Rahimi
Position
Professor
Latest degree
Specialist
Other areas of specialty/work
Anesthesiology
Street address
Anesthesia & critical care office, The building of the Vice-Chancellor of Academic Affairs, Imam Khomeini hospital complex, Dr. Qarib St., Keshavarz Blvd.
City
Tehran
Province
Tehran
Postal code
1419733141
Phone
+98 21 6119 2828
Email
dr.mojganrahimii@gmail.com

Person responsible for updating data

Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Alireza Rezaee
Position
Clinical resident
Latest degree
Medical doctor
Other areas of specialty/work
Anesthesiology
Street address
No. 8, Samadi Alley, Khojastehpoor St., Sattari HW.
City
Tehran
Province
Tehran
Postal code
1473713383
Phone
+98 21 6119 0000
Email
a_rezaee97@yahoo.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Yes - There is a plan to make this available
Informed Consent Form
Yes - There is a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Not applicable
Data Dictionary
Not applicable
Title and more details about the data/document
Data collected by questionnaires without patients' names; including demographic information, data obtained from monitoring methods during anesthesia and data related to the occurrence of complications during and after anesthesia
When the data will become available and for how long
Starting from one year after the results are published
To whom data/document is available
Researchers working in academic and scientific institutions
Under which criteria data/document could be used
In order to be used in scientific research in line with the present trial, if they provide documentation related to their study and the approval of the scientific institutions responsible for the study
From where data/document is obtainable
Trial's public accountability officer
What processes are involved for a request to access data/document
Submitting the application to the trial's public accountability officer (via SMS or email), referring and reviewing the application by the trial's scientific accountability officer, providing documentation by the public accountability officer after approval
Comments
Loading...